Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 4,947 | 13,918 | 11,089 | 32,444 | 43,386 |
| Cost of Goods | 15,535 | 11,706 | 21,971 | 22,458 | 28,632 |
| Gross Profit | -10,588 | 2,212 | -10,882 | 9,986 | 14,754 |
| Operating Expenses | 6,159 | 6,719 | 11,053 | 12,489 | 9,389 |
| Operating Income | -16,747 | -4,507 | -21,935 | -2,503 | 5,365 |
| Interest Expense | 2,380 | 587 | 230 | 119 | 195 |
| Other Income | 3,705 | 1,319 | 136 | 220 | 225 |
| Pre-tax Income | -15,422 | -3,775 | -22,029 | -2,402 | 5,395 |
| Income Tax | -114 | -285 | -4,666 | 1,136 | 2,120 |
| Net Income Continuous | -15,308 | -3,490 | -17,363 | -3,538 | 3,275 |
| Minority Interests | 346 | 136 | 275 | 318 | 101 |
| Net Income | $-14,962 | $-3,354 | $-17,088 | $-3,220 | $3,376 |
| EPS Basic Total Ops | -0.11 | -0.02 | -0.13 | -0.03 | 0.03 |
| EPS Basic Continuous Ops | -0.11 | -0.02 | -0.13 | -0.03 | 0.03 |
| EPS Diluted Total Ops | -0.11 | -0.02 | -0.13 | -0.03 | 0.02 |
| EPS Diluted Continuous Ops | -0.11 | -0.02 | -0.13 | -0.03 | 0.02 |
| EBITDA(a) | $-11,737 | $-2,004 | $-20,673 | $-1,512 | $6,129 |